Pharmaceutical Attorneys Dangerous Drugs Defective Medical Devices Medical Conditions Currently Accepted Cases Our Lawyers Do I Have a Case? Contact Us

Popular Antibiotic Could Unexpectedly Kill You

According to a new warning from the Food and Drug Administration (FDA), the widely prescribed antibiotic Azithromycin may cause heart problems and unexpected death.

In a statement released on March 13, the FDA explained that Azithromycin, also sold as Zithromax or the Z-Pak, can cause abnormal changes in the heart's electrical activity, which could lead to a potentially deadly irregular heart rhythm.

The patients most at risk are those with low levels of magnesium or potassium in the blood and/or heart rates that are slower than normal, according to the FDA. People who take drugs for irregular heart rhythms are at risk as well.

In response to the new FDA warning, Pfizer, the manufacturer of Zithromax, updated the drug's label about the potential that it may cause heart rhythm abnormalities in some patients. "It is important to note that other macrolide antibiotics are similarly labeled," the drug company noted in a statement made to USA Today. "It is also important to note that the majority of patients treated with Zithromax (azithromycin) are not affected by this label update."

The Z-Pak is used to treat everything from ear and lung infections, to infections in the reproductive organ, sinuses, skin and throat. The Z-pak comes in both liquid and tablet form. In addition to the potentially deadly side effects, the drug can also cause abdominal pain, diarrhea, nausea and vomiting.

Medtronic's False Promotion for Off-Label Use of Infuse Bone Graft Device
A lot takes place behind closed doors in the pharmaceutical industry, whether it is for drugs or medical devices. As consumers and patients, we often ... Read More [+]
J&J Paid $1 Billion to the U.S. for Risperdal Marketing Investigation
After a civil investigation early last year, Johnson & Johnson received a penalty for the marketing methods of their antipsychotic medication Risp... Read More [+]
FDA Defends Proposal for Generic Drug Manufacturers
After several key probes from the bench in unfortunate yet binding decisions on the issue of product liability for generic drugs, the United States Fo... Read More [+]